クリップ | Code No. | 品名 | データ | ||||
---|---|---|---|---|---|---|---|
データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
配列 | 位置 | 温度 | |||||
|
|||||||
TS-M098-2 |
HLA-A*02:01 HA-8 Tetramer-RTLDKVLEV-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RTLDKVLEV | 149-157 | 4°C | |||||
TB-7310-K4 |
QuickSwitch™ Quant HLA-B*07:02 Tetramer Kit-BV421 |
||||||
Others | BV421 | B*07:02 | 1 kit | ¥157,000 |
0 (お問合せ) |
||
- | - | 4°C | |||||
TS-M064-2 |
HLA-A*24:02 Adenovirus 11 Hexon696-704 Tetramer-VYSGSIPYL-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VYSGSIPYL | 696-704 | 4°C | |||||
TB-M047-1 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLPQLCTEL | 18-26 | 4°C | |||||
TB-M099-1 |
HLA-B*07:02 CMV pp65 Tetramer-RPHERNGFTVL-PE |
||||||
virus CMV |
PE | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RPHERNGFTVL | 265-275 | 4°C | |||||
TB-0014-2 |
T-Select HLA-A*02:01 gp100 (wild) Tetramer-ITDQVPFSV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ITDQVPFSV | 209-217 | 4°C | |||||
TS-M132-2 |
HLA-A*02:01 Mtb 16 kDa Tetramer-GILTVSVAV-APC |
||||||
bacteria | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
GILTVSVAV | 120-128 | 4°C | |||||
TS-M136-1 |
HLA-A*24:02 PBF A24.2 Tetramer-AYRPVSRNI-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
AYRPVSRNI | 145-153 | 4°C | |||||
TS-M092-2 |
HLA-A*02:01 measles virus HA Tetramer-KLWCRHFCV-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KLWCRHFCV | 576-584 | 4°C | |||||
TS-M136-2 |
HLA-A*24:02 PBF A24.2 Tetramer-AYRPVSRNI-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
AYRPVSRNI | 145-153 | 4°C | |||||
TB-0029-1 |
T-Select HLA-A*02:01 Negative Tetramer-PE |
||||||
negative | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
4°C | |||||||
TB-7300-KM |
QuickSwitch™ Quant HLA-A*02:01 Peptide Screening Kit |
||||||
Others | A*02:01 | 96 Well | ¥330,000 |
0 (お問合せ) |
|||
- | - | 4°C | |||||
TB-M047-2 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLPQLCTEL | 18-26 | 4°C | |||||
TS-M018-1 |
T-Select HLA-A*24:02 HTLV-1 Tax301-309 Tetramer-SFHSLHLLF-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 | 1-9 | ||
SFHSLHLLF | 301-309 | 4°C | |||||
TB-0025-2 |
T-Select HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAM-APC |
||||||
virus CMV |
APC | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
TPRVTGGGAM | 417-426 | 4°C | |||||
TS-M014-2 |
T-Select HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 | 1-9 | ||
CYTWNQMNL | 235-243 | 4°C | |||||
TS-M151-3 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-FITC |
||||||
negative | FITC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ALAAAAAAV | 4°C | ||||||
TB-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RMPEAAPPV | 65-73 | 4°C | |||||
TS-M094-1 |
HLA-A*02:01 H-Y Tetramer-FIDSYICQV-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
FIDSYICQV | 311-319 | 4°C | |||||
TS-M016-2 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RMFPNAPYL | 126-134 | 4°C | |||||
TB-0148-4 |
HLA-B*27:05 HIV env Tetramer-GRAFVTIGK-BV421 |
||||||
virus HIV |
BV421 | B*27:05 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GRAFVTIGK | 103-111 | 4°C | |||||
TB-M057-1 |
HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLEETSVML | 316-324 | 4°C | |||||
TS-M151-1 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-PE |
||||||
negative | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
ALAAAAAAV | 4°C | ||||||
TB-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLFFYRKSV | 4°C | ||||||
TS-M018-2 |
T-Select HLA-A*24:02 HTLV-1 Tax301-309 Tetramer-SFHSLHLLF-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SFHSLHLLF | 301-309 | 4°C | |||||
TB-0170-1 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLQVFLIVL | 5-13 | 4°C | |||||
TS-M152-1 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE |
||||||
negative | PE | A*11:01 | 50 tests | ¥209,000 | 1-9 | ||
ATAAAAAAK | 4°C | ||||||
TS-M151-2 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-APC |
||||||
negative | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ALAAAAAAV | 4°C | ||||||
TB-0116-2 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-APC |
||||||
virus LCMV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLVSIFLHL | 4°C | ||||||
TB-0110-4 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLFLLFSL | 4°C | ||||||
TB-0140-2 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EYILSLEEL | 298-306 | 4°C | |||||
TB-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RYCNLEGPPI | 177-186 | 4°C | |||||
TS-M152-2 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC |
||||||
negative | APC | A*11:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ATAAAAAAK | 4°C | ||||||
TB-M075-1 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KVAELVHFL | 112-120 | 4°C | |||||
TS-M152-3 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-FITC |
||||||
negative | FITC | A*11:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ATAAAAAAK | 4°C | ||||||
TB-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLYDDNQRV | 828-836 | 4°C | |||||
TS-M077-2 |
HLA-A*24:02 MAGE-A3 Tetramer-IMPKAGLLI-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
IMPKAGLLI | 195-203 | 4°C | |||||
TB-M040-2 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-APC |
||||||
virus HCV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLVALGINAV | 1406-1415 | 4°C | |||||
TS-M026-1 |
T-Select HLA-A*02:01 MPT51 Tetramer-TLAGKGISVV-PE |
||||||
bacteria | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TLAGKGISVV | 53-62 | 4°C | |||||
TS-M091-1 |
HLA-A*24:02 MCPyV large T Ag Tetramer-EWWRSGGFSF-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
EWWRSGGFSF | 92-101 | 4°C | |||||
TS-M091-2 |
HLA-A*24:02 MCPyV large T Ag Tetramer-EWWRSGGFSF-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
EWWRSGGFSF | 92-101 | 4°C | |||||
TB-M055-1 |
HLA-B*35:01 HIV RT Tetramer-NPDIVIYQY-PE |
||||||
virus HIV |
PE | B*35:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
NPDIVIYQY | 175-183 | 4°C | |||||
TB-M074-4 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-BV421 |
||||||
cancer | BV421 | A*01:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EVDPIGHLY | 168-176 | 4°C | |||||
TS-M021-1 |
T-Select HLA-A*24:02 HTLV-1 Tax187-195 Tetramer-PYKRIEELL-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 | 1-9 | ||
PYKRIEELL | 187-195 | 4°C | |||||
TB-0111-4 |
HLA-B*27:05 Influenza NP Tetramer-SRYWAIRTR-BV421 |
||||||
virus Influenza |
BV421 | B*27:05 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SRYWAIRTR | 4°C | ||||||
TB-0108-4 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-BV421 |
||||||
cancer | BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RISTFKNWPK | 4°C | ||||||
TB-0025-4 |
T-Select HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAM-BV421 |
||||||
virus CMV |
BV421 | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
TPRVTGGGAM | 417-426 | 4°C | |||||
TB-0012-4 |
T-Select HLA-A*02:01 Influenza-M1 Tetramer-GILGFVFTL-BV421 |
||||||
virus Influenza |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GILGFVFTL | 58-66 | 4°C | |||||
TB-0119-4 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-BV421 |
||||||
cancer | BV421 | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LPWHRLFLL | 208-216 | 4°C | |||||
TB-0102-2 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
HLVEALYLV | 4°C | ||||||
TB-0029-4 |
T-Select HLA-A*02:01 Negative Tetramer-BV421 |
||||||
negative | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
4°C | |||||||
TB-0129-2 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-APC |
||||||
cancer | APC | B*35:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
MPFATPMEA | 94-102 | 4°C | |||||
TS-M044-1 |
HLA-A*24:02 HCV E2 717-725 Tetramer-EYVLLLFLL-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
EYVLLLFLL | 717-725 | 4°C | |||||
TB-0029-2 |
T-Select HLA-A*02:01 Negative Tetramer-APC |
||||||
negative | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
4°C | |||||||
TB-0109-4 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-BV421 |
||||||
virus HIV |
BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLRPGGKKK | 4°C | ||||||
TB-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KVLEYVIKV | 278-286 | 4°C | |||||
TB-M011-4 |
T-Select HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLMWITQC | 157-165 | 4°C | |||||
TB-0167-4 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-BV421 |
||||||
cancer | BV421 | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RYCNLEGPPI | 177-186 | 4°C | |||||
TB-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RMPEAAPPV | 65-73 | 4°C | |||||
TS-M023-1 |
T-Select HLA-A*11:01 HTLV-1 Tax88-96 Tetramer-KVLTPPITH-PE |
||||||
virus | PE | A*11:01 | 50 tests | ¥209,000 | 1-9 | ||
KVLTPPITH | 88-96 | 4°C | |||||
TS-M024-1 |
T-Select HLA-A*11:01 HTLV-1 Tax272-280 Tetramer-QSSSFIFHK-PE |
||||||
virus | PE | A*11:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
QSSSFIFHK | 272-280 | 4°C | |||||
TB-M076-1 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLWGPRALV | 271-279 | 4°C | |||||
TB-M053-1 |
HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLLSLGIHL | 575-583 | 4°C | |||||
TB-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTV | 4°C | ||||||
TB-0118-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer CVNGVCWTV-APC |
||||||
virus HCV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CVNGVCWTV | 4°C | ||||||
TB-0101-2 |
HLA-B*15:01 EBV EBNA4 Tetramer-GQGGSPTAM-APC |
||||||
virus EBV |
APC | B*15:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GQGGSPTAM | 4°C | ||||||
TB-M014-4 |
HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-BV421 |
||||||
cancer | BV421 | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CYTWNQMNL | 235-243 | 4°C | |||||
TB-0164-2 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YMCSFLFNL | 666-674 | 4°C | |||||
TB-0148-2 |
HLA-B*27:05 HIV env Tetramer-GRAFVTIGK-APC |
||||||
virus HIV |
APC | B*27:05 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GRAFVTIGK | 103-111 | 4°C | |||||
TB-0130-1 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-PE |
||||||
virus HIV |
PE | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RYLKDQQLL | 67-75 | 4°C | |||||
TB-0168-4 |
HLA-B*35:01 EBV EBNA1 Tetramer-HPVGEADYFEY-BV421 |
||||||
virus EBV |
BV421 | B*35:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
HPVGEADYFEY | 4°C | ||||||
TB-0144-1 |
HLA-B*07:02 H-Y Tetramer-SPSVDKARAEL-PE |
||||||
Others | PE | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SPSVDKARAEL | 4°C | ||||||
TB-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLFFYRKSV | 4°C | ||||||
TB-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLFLLFSL | 4°C | ||||||
TB-0009-4 |
T-Select HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ELAGIGILTV | 26-35 | 4°C | |||||
TB-0162-1 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLFGLGFAI | 265-273 | 4°C | |||||
TB-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
||||||
cancer | BV421 | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EYILSLEEL | 298-306 | 4°C | |||||
TB-0138-1 |
HLA-A*03:01 HIV Nef Tetramer-QVPLRPMTYK-PE |
||||||
virus HIV |
PE | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
QVPLRPMTYK | 73-82 | 4°C | |||||
TS-M019-1 |
T-Select HLA-A*02:01 HTLV-1 Tax178-186 Tetramer-QLGAFLTNV-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
QLGAFLTNV | 178-186 | 4°C | |||||
TS-M033-2 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-APC |
||||||
virus | APC | A*03:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RLRAEAQVK | 603-611 | 4°C | |||||
TS-M079-2 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TB-0123-2 |
HLA-B*07:02 EBV EBNA 6 Tetramer-QPRAPIRPI-APC |
||||||
virus EBV |
APC | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
QPRAPIRPI | 4°C | ||||||
TB-0122-2 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-APC |
||||||
virus HBV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLLTRILTI | 4°C | ||||||
TB-0107-2 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LNIDLLWSV | 4°C | ||||||
TB-0105-1 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-PE |
||||||
cancer | PE | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLFGVLRLK | 4°C | ||||||
TB-0102-4 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-BV421 |
||||||
Others | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
HLVEALYLV | 4°C | ||||||
TB-0102-1 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
HLVEALYLV | 4°C | ||||||
TB-M039-2 |
HLA-A*02:01 HCV NS31073-1081 Tetramer-CINGVCWTV-APC |
||||||
virus HCV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CINGVCWTV | 1073-1081 | 4°C | |||||
TB-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLWGPRALV | 271-279 | 4°C | |||||
TB-M016-4 |
T-Select HLA-A*02:01 WT-1126-134 Tetramer-RMFPNAPYL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RMFPNAPYL | 126-134 | 4°C | |||||
TB-0026-4 |
T-Select HLA-B*08:01 CMV IE1 Teramer-ELRRKMMYM-BV421 |
||||||
virus CMV |
BV421 | B*08:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ELRRKMMYM | 199-207 | 4°C | |||||
TB-0023-4 |
T-Select HLA-A*24:02 HBV pol Tetramer-KYTSFPWLL-BV421 |
||||||
virus HBV |
BV421 | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KYTSFPWLL | 756-764 | 4°C | |||||
TB-0167-2 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RYCNLEGPPI | 177-186 | 4°C | |||||
TB-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TB-0139-1 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CYASGWGSI | 153-161 | 4°C | |||||
TS-M020-1 |
T-Select HLA-A*24:02 HTLV-1 Tax12-20 Tetramer-LFGYPVYVF-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 | 1-9 | ||
LFGYPVYVF | 12-20 | 4°C | |||||
TS-M049-2 |
HLA-A*24:02 HPV16 E6 Tetramer-VYDFAFRDL-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 | 1-9 | ||
VYDFAFRDL | 49-57 | 4°C | |||||
TS-M056-2 |
HLA-A*01:01 RSV M229-237 Tetramer-YLEKESIYY-APC |
||||||
virus | APC | A*01:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
YLEKESIYY | 229-237 | 4°C | |||||
TS-M083-1 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KLQDASAEV | 126-134 | 4°C | |||||
TB-0014-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (ITDQVPFSV) |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ITDQVPFSV | 209-217 | 4°C |
※在庫につきましては2024年04月26日 17時33分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。